Table 2 Imaging findings at baseline, 3, 6 and 12 months in patients with early rheumatoid arthritis

Measure	Baseline	3 Months	6 Months	12 Months	p Value*
RAMRIS synovitis (range 0–9)	5.0 (3.0–6.0)	5.0 (3.0–6.0)	4.0 (3.0–5.0)	4.0 (3.0–5.0)	<0.001
RAMRIS erosions (range 0–150)	8.0 (5.0–11.0)	8.5 (6.0–12.0)	9.0 (5.0–12.0)	9.0 (6.0–13.0)	<0.001
RAMRIS bone marrow oedema (range 0–45)	2.0 (1.0–6.0)	2.0 (1.0–4.0)	2.0 (1.0–4.0)	2.0 (1.0–4.0)	0.03
MRI tenosynovitis (range 0–30)	9.0 (6.0–11.0)	8.0 (5.0–10.0)	7.0 (5.0–9.0)	7.0 (5.0–9.0)	0.001
vdHSS erosions (range 0–160)	1.0 (0.0–2.0)	1.0 (0.0–3.0)	1.0 (0.0–3.0)	1.0 (0.0–3.0)	<0.001
vdHSS JSN (range 0–120)	0.0 (0.0–2.0)	0.0 (0.0–3.0)	0.0 (0.0–4.0)	0.0 (0.0–4.0)	0.007
Total vdHSS (range 0–280)	2.0 (0.0–5.0)	2.0 (0.0–6.0)	2.0 (0.0–7.0)	2.0 (1.0–8.0)	<0.007

Results are shown as median (IQR).
*Wilcoxon signed ranks test.
JSN, joint space narrowing; MRI, magnetic resonance imaging; RAMRIS, rheumatoid arthritis magnetic resonance imaging score; vdHSS, van der Heijde modified Sharp score.